Research is ongoing to develop interventions that target ACT. Potential strategies include vaccine development that elicits neutralizing antibodies against the toxin, or small molecules that inhibit its enzymatic activity. Additionally, understanding the structural biology of ACT could aid in the design of inhibitors that block its interaction with host cells.
